Lineage Cell Therapeutics (LCTX) Q4 2024 Earnings

Nov 14Confirmed
Q4 2023
Q2 2024
Q3 2024
Q4 2024
-0.05
-0.04
-0.03
-0.02

Details

Expected EPS
-0.04
Actual EPS
-0.02
Surprise EPS
0.02
Surprise Percent
+50%

Description

⁨Lineage Cell Therapeutics⁩ (⁦LCTX⁩) has reported earnings of ⁦-0.02⁩ per share for ⁦Q4 2024⁩.

0 Comments

Share your thoughts